207 articles
Taking pride of place in an unmissable position on its large stand at the front of the exhibition hall for ODMA’s 2025 optical fair in Sydney, was EssilorLuxottica’s latest market offering: Nuance Aud
After a quiet start to the first morning, visitor numbers at the 2025 ODMA three-day fair at Sydney’s ICC conference and exhibition centre increased rapidly, attracting more than 3,300 visitors from independent practices across Australasia, including 60 from New Zealand.
With a brand-new catalogue, a streamlined website and newly organised, simple-to-understand product ranges, including its bespoke case, cloth and lens cleaner packages, Optica Life Accessories was celebrating months of hard work to make everything much simpler for customers at ODMA25.
Well-known New Zealand eyewear distributor Little Peach took a double booth at ODMA25 as part of its new push across the Tasman for its brand Face & Cie.
In the week leading up to ODMA’s 2025 fair, Marchon threw open its doors for its first ever ‘First View 2025’, giving customers the opportunity to see its full October 2025 eyewear release.
According to research from Massey University, the risk of burnout is twice as high for medical doctors compared with other workforce groups in Aotearoa. Though the Medscape Physician Burnout & Depre
With a shortage of ophthalmologists in the regions, RANZCO’s education committee surveyed 23 New Zealand-based ophthalmology trainees and a few recently made fellows to understand what mattered to them after they completed their training. Presenting the results at the RANZCO NZ 2025 conference in Ro
iScribe, an artificial intelligence (AI) note-taking tool that converts patient conversations into clinical notes, referrer and patient letters, has gained 15-20% of the Australian ophthalmology market since its launch at the beginning of 2024, reported its parent company Akuru.
The prevalence of childhood blindness in Aotearoa has fallen from 0.05% in 2012 to 0.01% in 2024 and low vision from 0.06% to 0.03%, according to a new study led by Dr Cheefoong Chong.
New trial unveiled to examine Vuity eye drops’ (pilocarpine 1.25%) broader pharmacological effects
Adding real-world data and insights to years of positive clinical trial results, UK consultant ophthalmologist and medical retina specialist Dr Christiana Dinah was the keynote speaker at a recent closed-door event for Vabysmo (faricimab, Roche).
Following nibbles and drinks, the 2025 Excellence in Ophthalmology and Vision Research awards at the University of Auckland were introduced by Professor Charles McGhee, the long-standing Maurice Paykel Chair of Ophthalmology and founding director of the New Zealand National Eye Centre. Despite the u
